Free Trial

Globus Medical (GMED) Stock Price, News & Analysis

Globus Medical logo
$61.54 -0.34 (-0.54%)
Closing price 08/27/2025 03:59 PM Eastern
Extended Trading
$61.25 -0.29 (-0.48%)
As of 07:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Globus Medical Stock (NYSE:GMED)

Key Stats

Today's Range
$61.15
$61.92
50-Day Range
$51.94
$62.91
52-Week Range
$51.79
$94.93
Volume
1.06 million shs
Average Volume
1.44 million shs
Market Capitalization
$8.31 billion
P/E Ratio
23.67
Dividend Yield
N/A
Price Target
$87.64
Consensus Rating
Moderate Buy

Company Overview

Globus Medical Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
99th Percentile Overall Score

GMED MarketRank™: 

Globus Medical scored higher than 99% of companies evaluated by MarketBeat, and ranked 21st out of 945 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Globus Medical has received a consensus rating of Moderate Buy. The company's average rating score is 2.62, and is based on 8 buy ratings, 5 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Globus Medical has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Globus Medical's stock forecast and price target.
  • Earnings Growth

    Earnings for Globus Medical are expected to grow by 17.15% in the coming year, from $3.44 to $4.03 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Globus Medical is 23.67, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 28.63.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Globus Medical is 23.67, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 30.85.

  • Price to Earnings Growth Ratio

    Globus Medical has a PEG Ratio of 1.73. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Globus Medical has a P/B Ratio of 1.93. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Globus Medical's valuation and earnings.
  • Percentage of Shares Shorted

    4.33% of the float of Globus Medical has been sold short.
  • Short Interest Ratio / Days to Cover

    Globus Medical has a short interest ratio ("days to cover") of 2.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Globus Medical has recently increased by 5.75%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Globus Medical does not currently pay a dividend.

  • Dividend Growth

    Globus Medical does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    4.33% of the float of Globus Medical has been sold short.
  • Short Interest Ratio / Days to Cover

    Globus Medical has a short interest ratio ("days to cover") of 2.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Globus Medical has recently increased by 5.75%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Globus Medical has a news sentiment score of 1.52. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.99 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 14 news articles for Globus Medical this week, compared to 15 articles on an average week.
  • Search Interest

    Only 4 people have searched for GMED on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
  • MarketBeat Follows

    Only 1 people have added Globus Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of -67% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Globus Medical insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    18.51% of the stock of Globus Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    95.16% of the stock of Globus Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Globus Medical's insider trading history.
Receive GMED Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Globus Medical and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

GMED Stock News Headlines

Chase, Bank of America, Wells Fargo Preparing for BIG Change
Thanks to this brand-new law #S.1582 signed by President Trump… Jeff Brown believes the largest banks in America could soon begin to replace every single dollar in your bank account… With a better, more technologically advanced dollar… Potentially making a lot of people rich in the process.tc pixel
Citizens JMP Remains a Hold on Globus Medical (GMED)
2 Healthcare Stocks to Consider Right Now and 1 We Find Risky
See More Headlines

GMED Stock Analysis - Frequently Asked Questions

Globus Medical's stock was trading at $82.71 at the beginning of the year. Since then, GMED shares have decreased by 25.6% and is now trading at $61.5430.

Globus Medical, Inc. (NYSE:GMED) issued its quarterly earnings results on Thursday, August, 7th. The medical device company reported $0.86 earnings per share for the quarter, beating analysts' consensus estimates of $0.76 by $0.10. Globus Medical's revenue was up 18.4% on a year-over-year basis.
Read the conference call transcript
.

Globus Medical's board initiated a stock buyback plan on Thursday, May 15th 2025, which authorizes the company to buy back $500,000,000 in outstanding shares, according to EventVestor. This means that the company could buy up to 6.3% of its shares through open market purchases. Shares buyback plans are often a sign that the company's management believes its shares are undervalued.

Top institutional shareholders of Globus Medical include Burgundy Asset Management Ltd. (2.57%), State Street Corp (2.57%), Sculptor Capital LP (2.04%) and William Blair Investment Management LLC (1.78%). Insiders that own company stock include David D Davidar, Ann D Rhoads, Leslie V Norwalk, Daniel T Scavilla, Dan Lemaitre, Keith W Pfeil and Kelly Huller.
View institutional ownership trends
.

Shares of GMED stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Globus Medical investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), CrowdStrike (CRWD), Arista Networks (ANET), Advanced Micro Devices (AMD) and ServiceNow (NOW).

Company Calendar

Last Earnings
8/07/2025
Today
8/28/2025
Next Earnings (Estimated)
11/04/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Health Care Equipment
Current Symbol
NYSE:GMED
CIK
1237831
Employees
5,300
Year Founded
2003

Price Target and Rating

High Price Target
$115.00
Low Price Target
$66.00
Potential Upside/Downside
+42.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.62
Research Coverage
13 Analysts

Profitability

EPS (Trailing Twelve Months)
$2.60
Trailing P/E Ratio
23.67
Forward P/E Ratio
17.89
P/E Growth
1.73
Net Income
$102.98 million
Net Margins
13.58%
Pretax Margin
14.22%
Return on Equity
10.65%
Return on Assets
8.86%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.07
Quick Ratio
2.26

Sales & Book Value

Annual Sales
$2.52 billion
Price / Sales
3.30
Cash Flow
$6.62 per share
Price / Cash Flow
9.29
Book Value
$31.81 per share
Price / Book
1.93

Miscellaneous

Outstanding Shares
135,060,000
Free Float
110,058,000
Market Cap
$8.31 billion
Optionable
Optionable
Beta
1.20

Social Links

7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

This page (NYSE:GMED) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners